Skip to content

Observational clinical trial of laparoscopic exploration in the evaluation of peritoneal metastasis and ascites cfdna detection of pancreatic cancer

Observational clinical trial of laparoscopic exploration in the evaluation of peritoneal metastasis and ascites cfdna detection of pancreatic cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100956
Enrollment
Unknown
Registered
2025-04-17
Start date
2023-12-01
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Case series:NA

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old, regardless of gender; 2. Pathological diagnosis was pancreatic adenocarcinoma; 3. Advanced pancreatic cancer with intraperitoneal metastasis was evaluated by imaging, or intraperitoneal metastasis was found during operation; 4. After evaluation, laparoscopic exploration can be performed; 5. Voluntarily participate and sign the informed consent;

Exclusion criteria

Exclusion criteria: 1. Accompanied by malignant tumors of other systems; 2. No surgery or severe intraoperative adhesion can not be fully staged; 3. Central nervous system disease, mental disease, unstable angina pectoris, congestive heart failure, severe arrhythmia and other uncontrollable serious diseases; 4. Reject gene testing or ctDNA testing.

Design outcomes

Primary

MeasureTime frame
peritoneal metastasis;

Secondary

MeasureTime frame
ctDNA;

Countries

China

Contacts

Public ContactYu Xianjun

Fudan University Shanghai Cancer Center

yuxianjun@fudanpci.org+86 21 64175590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026